Literature DB >> 6787109

Effects of a single high oral dose of thyroxine on the pituitary-thyroid-axis.

H G Hoff, K Hackenberg, D Reinwein.   

Abstract

Ten euthyroid and 9 hypothyroid volunteers were orally administered 2 mg L-thyroxine (T4) to study the interaction between substitutive and suppressive effects of a single high T4 dose. After a significant rise the serum T4 concentration for 5 days in euthyroid and for 11 days in hypothyroid patients an inhibition of basal and of TRH stimulated TSH release was observed. Maximal inhibition of the TSH response in hypothyroid patients occurred 1 to 7 days after the individual T4 peak. This interval was significantly correlated to the extent of the respective T4 rise. In euthyroid subjects TSH response was significantly inhibited for 8, in hypothyroid patients for 22 days. In all but 3 of the euthyroid patients there was a significant inhibition of the thyroidal 132I uptake on day 8. Normalization of thyroidal 132I uptake and of pituitary TSH secretion generally coincided.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6787109     DOI: 10.1007/BF03349413

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

Review 1.  TRANSPORT OF IODIDE AND OTHER ANIONS IN THE THYROID GLAND.

Authors:  J WOLFF
Journal:  Physiol Rev       Date:  1964-01       Impact factor: 37.312

2.  Thyroidal suppression by triiodothyronine as a guide to duration of treatment of thyrotoxicosis with antithyroid drugs.

Authors:  W D Alexander; R M Harden; J Shimmins
Journal:  Lancet       Date:  1966-11-12       Impact factor: 79.321

Review 3.  The action of thyrotropin on thyroid metabolism.

Authors:  J E Dumont
Journal:  Vitam Horm       Date:  1971       Impact factor: 3.421

4.  Administration of thyroxin once a week.

Authors:  C B Sekadde; W R Slaunwhite; T Aceto; K Murray
Journal:  J Clin Endocrinol Metab       Date:  1974-10       Impact factor: 5.958

5.  A thyroid suppression test using a single dose of L-thyroxine.

Authors:  M S Wallack; H M Adelberg; J T Nicoloff
Journal:  N Engl J Med       Date:  1970-08-20       Impact factor: 91.245

6.  Acute metabolic responses in myxedema to large doses of intravenous L-thyroxine.

Authors:  E C Ridgway; J A McCammon; J Benotti; F Maloof
Journal:  Ann Intern Med       Date:  1972-10       Impact factor: 25.391

7.  A study on the interaction of the thyrotropin-releasing factor and L-triiodothyronine: effects of puromycin and cycloheximide.

Authors:  C Y Bowers; K L Lee; A V Schally
Journal:  Endocrinology       Date:  1968-01       Impact factor: 4.736

8.  [Restitution of the thyrotropic function in goiter patients after discontinuing a long-term suppression therapy with thyroid hormones].

Authors:  M Hüfner; M Grussendorf; R Wahl; H D Röher
Journal:  Klin Wochenschr       Date:  1976-06-01

9.  Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy.

Authors:  A G Vagenakis; L E Braverman; F Azizi; G I Portinay; S H Ingbar
Journal:  N Engl J Med       Date:  1975-10-02       Impact factor: 91.245

10.  Studies on the control of thyrotrophin secretion in normal man.

Authors:  P A Vice; F Clark; W Schardt; D Evered
Journal:  Clin Endocrinol (Oxf)       Date:  1976-09       Impact factor: 3.478

View more
  1 in total

1.  Different rates of thyrotropin suppression after total body scan in patients with thyroid cancer: effect of an optimal saturation regimen with thyroxine or triiodothyronine.

Authors:  B Busnardo; F Bui; M E Girelli
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.